97 Cost-Benefit Analysis of Prevention of Neonatal Anemia With Recombinant Human Erythropoietin in Premature Infants
Pediatric Research - United States
doi 10.1203/00006450-200409000-00120
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2004
Authors
Publisher
Springer Science and Business Media LLC